Neurontin
Home >> Neurontin >> Drug Details
Gabapentin (brand name Neurontin) is a GABA analogue. It was originally developed for the treatment of epilepsy, and currently, gabapentin is widely used to relieve pain, especially neuropathic pain.
Pharmacology
Gabapentin was initially synthesized to mimic the chemical structure of the neurotransmitter gamma-aminobutyric acid (GABA), but is not believed to act on the same brain receptors.
Its exact mechanism of action is unknown, but its therapeutic action on neuropathic pain is thought to involve voltage-gated N-type calcium ion channels. It is thought to bind to the 2 subunit (1 and 2)[2] of the voltage-dependent calcium channel in the central nervous system.[3]
Indications
Due to the wide variety of conditions for which Gabapentin may be considered as a treatment, and the various claims and counterclaims surrounding it, this presentation of the indicated uses of Gabapentin has attempted to separate the FDA accepted uses, the putative uses, and the disputed uses of the drug.
Proven
Gabapentin was originally approved in the U.S. by the Food and Drug Administration (FDA) in 1994 for use as an adjunctive medication to control partial seizures (effective when added to other antiseizure drugs). In 2002, an indication was added for treating postherpetic neuralgia (neuropathic pain following shingles), other painful neuropathies, and nerve related pain.[4]
Gabapentin (administered orally) is one of two medications (the other being flumazenil, which is administered intravenously) used in the expensive Prometa Treatment Protocol for methamphetamine, cocaine and alcohol addiction. Gabapentin is administered at a dosage of 1200 mg taken at bedtime for 4060 days. Though the combination of flumazenil infusions and gabapentin tablets is a licensed treatment, there is no prohibition against a physician prescribing gabapentin outside the Prometa protocol. There have been reports by methamphetamine addicts that gabapentin alone in doses of 1200 mg at bedtime taken for 4060 days has been effective in reducing the withdrawal symptoms and almost eliminating cravings or desire to use methamphetamine.[5] It also helps those addicted to prescribed pain medications, and reduces withdrawal symptoms.[citation needed]
Positive
Gabapentin is frequently used to treat various types of Neuralgia. It has been found to be effective in prevention of frequent migraine headaches,[6] neuropathic pain[7] and nystagmus,[8] and is prescribed off-label (that is, without formal regulatory agreement) for these conditions. Gabapentin is widely believed to help patients with post-operative chronic pain (usually caused by nerves that have been severed accidentally in an operation and when grown back, have reconnected incorrectly) and nerve pain associated with spinal cord injury. It may be effective in reducing pain and spasticity in multiple sclerosis.[9], and has also had success in treating certain instances of Complex Regional Pain Syndrome.[10][11]
It is not uncommon for the prescription of Gabapentin to occur in a mental health context. It has been investigated as a mood-stabilizing treatment for bipolar disorder with the potential therapeutic advantage of having fewer side-effects than better established bipolar drugs such as lithium and valproic acid although numerous trials have shown that it is not effective. Gabapentin has limited usefulness in the treatment of anxiety disorders such as social anxiety disorder and obsessive-compulsive disorder, in treatment-resistant depression, and for insomnia.[12][13]
Additionally, Gabapentin has been prescribed to menopausal patients being treated with anti-androgenic compounds to reduce the incidence and intensity of the accompanying hot flashes[14]. It has occasionally been prescribed for treatment of idiopathic subjective tinnitus, although a double blind, randomized controlled trial has found this ineffective.[15] Gabapentin may help deepen sleep, positively affecting stage 4 sleep, and reducing arousals during the night [16].[citation needed] It could potentially be helpful for both sleep onset and sleep maintenance.[citation needed] Gabapentin is sometimes prescribed for RLS (Restless Legs Syndrome). Finally, it may be effective in treating akathisia - a rare side effect of typical antipsychotics that causes severe agitation and anxiety.[citation needed]
Gabapentin has also been used to treat some symptoms of opiate withdrawal.[17]
Negative
There has been a growing controversy regarding the psychiatric off-label use of Gabapentin.[9] Although some small, non-controlled studies in the 1990s mostly sponsored by gabapentin's manufacturer suggested that gabapentin treatment for bipolar disorder may be promising,[9] other more recent and better controlled studies have found it to be no more effective (and in one study, slightly less effective) than placebo.[18] Subsequent to the corporate acquisition of the original patent holder, the pharmaceutical company Pfizer admitted that there had been violations of FDA guidelines regarding the promotion of unproven off-label uses for Gabapentin in the Franklin v. Pfizer case. Concerns about the distorting effects of Pfizer's research practices upon the represented efficacy of Gabapentin have been summarized for the Prescription Access Litigation project in an August 10, 2008 article written by Kay Dickersin, M.D, Ph.D, a scholar of publication bias at Brown University.[19].
Despite this controversy, many psychiatrists continue to prescribe it for a variety of off-label purposes. It is often tried as an alternative treatment, when patients are unable to tolerate the side effect of more proven mood stabilizers such as lithium; as or more frequently, it is prescribed on a speculative basis as an auxiliary treatment, when single-drug therapy has consistently failed to yield sufficiently positive results. [20]
Precautions
Gabapentin should not be discontinued abruptly after long term use. Abrupt or over rapid withdrawal may provoke a withdrawal syndrome similar to alcohol or benzodiazepine withdrawal. Gradual reduction over a period of weeks or months helps minimize or prevents the withdrawal syndrome.[21]
Adverse effects
Gabapentin's most common side effects in adult patients include dizziness, drowsiness, and peripheral edema (swelling of extremities);[22] these mainly occur at higher doses, in the elderly. Also, children 312 years of age were observed to be susceptible to mild-to-moderate mood swings, hostility, concentration problems, and hyperactivity. Although rare, there are several cases of hepatotoxicity reported in the literature.[23] Gabapentin should be used carefully in patients with renal impairment due to possible accumulation and toxicity.[24][25]
An increase in formation of adenocarcinomas was observed in rats during preclinical trials, however the clinical significance of these results remains undetermined. Gabapentin is also known to induce pancreatic acinar cell carcinomas in rats through an unknown mechanism, perhaps by stimulation of DNA synthesis; these tumors did not affect the lifespan of the rats and did not metastasize.[26]
Recreational use
Although gabapentin is not a controlled substance, it does produce psychoactive effects that could lead to recreational use of the drug.[citation needed] However, it is widely regarded as having little or no potential for misuse. Pregabalin, a gabapentinoid with higher potency marketed for neuropathic pain, is a controlled substance, under Schedule V of the United States' Controlled Substances Act.
Risk of Suicide
The FDA has issued a warning of an increased risk of suicidal thoughts and behaviors in patients taking gabapentin. An independent analysis by the FDA showed that anticonvulsant drugs, including gabapentin, can increase suicidal thoughts in patients. The approved label for Neurontin now includes a warning about an increased risk of suicidal thoughts or actions and a guide to help patients understand this risk[27].
In July of 2009, the first case against Pfizer, the maker of Neurontin, went to trial, and there are an estimated 1200 pending cases regarding the safety of Neurontin. Although a Pfizer spokesperson noted that "the reliable scientific evidence does not demonstrate a causal association between Neurontin treatment and suicidal behavior," the FDA analysis found an 80 percent rise in suicidal thoughts and behavior in data from 199 studies of gabapentin and other anticonvulsants[28].
Sales
Gabapentin is best known under the brand name Neurontin manufactured by Pfizer subsidiary Parke-Davis. A Pfizer subsidiary named Greenstone markets generic gabapentin.
In December 2004, the FDA granted final approval to a generic equivalent to Neurontin made by the Israeli firm Teva.
Neurontin is one of Pfizers best-selling drugs, and was one of the 50 most-prescribed drugs in the United States in 2003. However, in recent years, Pfizer has come under heavy criticism for its marketing of Neurontin, facing allegations that, behind the scenes, Parke-Davis marketed the drug for at least a dozen supposed uses for which the drug had not been FDA approved.
Franklin v. Pfizer case
By some estimates, so-called off-label prescriptions account for roughly 90% of Neurontin sales.[29] While off-label prescriptions are common for a number of drugs and are perfectly legal (if not always appropriate), marketing of off-label uses of a drug is strictly illegal.[30] In 2004, Warner-Lambert agreed to plead guilty and pay $430 million in fines to settle civil and criminal charges regarding the illegal marketing of Neurontin for off-label purposes, and further legal action is pending. The courts of New York State, for example, have refused to certify a class of injured parties who took Neurontin for off-label use, finding that they had failed to state that they had any injury.[31]
The University of California, San Francisco (UCSF) has archived[32] and studied[33] the documents made public by this case, which opens a unique window into the illegal promotion and marketing of pharmaceuticals. However, Pfizer maintains that the illegal activity originated in 1996, well before it acquired Parke-Davis (through its acquisition of Warner-Lambert) in 2000. Several lawsuits are underway after people who had been prescribed gabapentin for off-label treatment of bipolar disorder later attempted or committed suicide.
Related drugs
Parke-Davis developed a drug called pregabalin to be a successor of gabapentin, which was brought to market by Pfizer as Lyrica after they acquired Warner-Lambert. Pregabalin is related in structure to gabapentin and is approved for treatment of epilepsy, neuropathic pain associated with diabetes, fibromyalgia, post-herpetic neuralgia, and generalized anxiety disorder.
References
- ^ BNF (March 2003) 45
- ^ Hendrich J, Van Minh AT, Heblich F, et al. (March 2008). "Pharmacological disruption of calcium channel trafficking by the alpha2delta ligand gabapentin". Proc. Natl. Acad. Sci. U.S.A. 105 (9): 362833. doi:10.1073/pnas.0708930105. PMID 18299583. PMC 2265195. http://www.pnas.org/cgi/pmidlookup?view=long&pmid=18299583.
- ^ Davies et al. Functional biology of the alpha(2)delta subunits of voltage-gated calcium channels.Trends Pharmacol Sci. 2007 May;28(5):220-8.
- ^ Pfizer: Product Monograph NeurontinPDF (251 KB) Retrieved 14 August 2006
- ^ PROMETA Demonstrates Statisitcally Significant Reduction in Methamphetamine Cravings in Randomized Double-Blind Placebo Controlled Study
- ^ Mathew, NT; Rapoport A, Saper J, Magnus L, Klapper J,hello Ramadan N, Stacey B, Tepper S (2001). "Efficacy of gabapentin in migraine prophylaxis". Headache 41 (2): 11928. doi:10.1046/j.1526-4610.2001.111006119.x. ISSN 0017-8748. PMID 11251695. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=11251695&itool=pubmed_citation. Retrieved 2006-08-14.
- ^ Backonja, MM; Serra J (2004). "Pharmacologic management part 1: better-studied neuropathic pain diseases". Pain Med 5 (Suppl 1): S2847. doi:10.1111/j.1526-4637.2004.04020.x. ISSN 1526-2375. PMID 14996228.
- ^ Choudhuri, I; Sarvananthan N, Gottlob I (May 26, 2006). "Survey of management of acquired nystagmus in the United Kingdom". Eye 21: 1194. doi:10.1038/sj.eye.6702434. ISSN 0950-222X. PMID 16732211.
- ^ a b c Mack, Alicia (2003). "Examination of the evidence for off-label use of gabapentin" (PDF). Journal of Managed Care Pharmacy 9 (6): 55968. http://www.amcp.org/data/jmcp/Contemporary%20Subject-559-568.pdf. Retrieved 2006-08-14.
- ^ Gabapentin: pharmacology and its use in pain management; Rose, M., Kam, P.
- ^ Randomised controlled trial of gabapentin in Complex Regional Pain Syndrome type 1, Anton C van de Vusse , Suzanne GM Stomp-van den Berg , Alfons HF Kessels and Wim EJ Weber.
- ^ Chouinard, G (May 2006). "The search for new off-label indications for antidepressant, antianxiety, antipsychotic and anticonvulsant drugs". J Psychiatry Neurosci 31 (3): 168176. ISSN 1180-4882. PMID 16699602.
- ^ Frye, Mark A.; et al. (2000). "A Placebo-Controlled Study of Lamotrigine and Gabapentin Monotherapy in Refractory Mood Disorders" (Abstract). Journal of Clinical Psychopharmacology 20 (6): 60714. doi:10.1097/00004714-200012000-00004. http://www.psychopharmacology.com/pt/re/jclnpsychopharm/abstract.00004714-200012000-00004.htm. Retrieved 2006-08-14.
- ^ Guttuso, T Jr; Kurlan R; McDermott MP; Kieburtz K (February 2003). "Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial". Obstet Gynecol 101 (2): 33745. doi:10.1016/S0029-7844(02)02712-6.
- ^ Piccirillo, JF; Finnell J, Vlahiotis A, Chole RA, Spitznagel E (2007). "Relief of idiopathic subjective tinnitus: is gabapentin effective?". Arch Otolaryngol Head Neck Surg 133 (4): 3907. doi:10.1001/archotol.133.4.390. PMID 17438255.
- ^ Legros, B; Bazil, CW (January 2003). "Effects of antiepileptic drugs on sleep architecture: a pilot study.". Sleep Med. 4 (1): 51-5.
- ^ Martínez-Raga, J; Sabater, A; Perez-Galvez, B; Castellano, M; Cervera, G (May 2004). "Add-on gabapentin in the treatment of opiate withdrawal". Progress in Neuro-Psychopharmacology and Biological Psychiatry 28 (3): 599-601.
- ^ Pande, AC; Crockatt JG, Janney CA, Werth JL, Tsaroucha G. (2000). "Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy" (Abstract). Bipolar Disorders 2 (3 Pt 2): 24955. doi:10.1034/j.1399-5618.2000.20305.x. PMID 11249802.
- ^ Reporting and other biases in studies of Neurontin for migraine, psychiatric/bipolar disorders, nociceptive pain, and neuropathic pain [1]PDF (251 KB) Retrieved 28 March 2009
- ^ Baldessarini, Ross J.; Leahy L, Arcona S, Gause D, Zhang W, Hennen J. (2007). "Patterns of Psychotropic Drug Prescription for U.S. Patients With Diagnoses of Bipolar Disorders" (Abstract). Psychiatric Serv[ices] 58 (58): 8591. doi:10.1176/appi.ps.58.1.85.
- ^ Tran KT, Hranicky D, Lark T, Jacob Nj (June 2005). "Gabapentin withdrawal syndrome in the presence of a taper". Bipolar Disord 7 (3): 3024. doi:10.1111/j.1399-5618.2005.00200.x. PMID 15898970. http://www3.interscience.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=1398-5647&date=2005&volume=7&issue=3&spage=302.
- ^ "FDA approved labeling for Neurontin capsules, tablets, and oral solution." (PDF). February 2005. http://www.fda.gov/cder/foi/label/2005/20235s029,20882s015,21129s016lbl.pdf. Retrieved 2008-12-30. Note that an updated labeling has been approved, but is not available online as of November 2006
- ^ Maria C Lasso-de-la-Vega Pharm.D (2001). "Gabapentin-associated hepatotoxicity" (Abstract). Am J Gastroenterol 96 (12): 34603462. doi:10.1111/j.1572-0241.2001.05357.x/abs. http://www.blackwell-synergy.com/links/doi/10.1111/j.1572-0241.2001.05357.x/abs. Retrieved 2007-02-14.
- ^ Ayhan DOGUKAN (2006). "Gabapentin-induced coma in a patient with renal failure" (Abstract). Hemodialysis International 10 (2): 168169. doi:10.1111/j.1542-4758.2006.00089.x. http://www.blackwell-synergy.com/doi/abs/10.1111/j.1542-4758.2006.00089.x?journalCode=hdi. Retrieved 2007-02-14.
- ^ Bookwalter T, Gitlin M (2005). "Gabapentin-induced neurologic toxicities" (Abstract). Pharmacotherapy 25 (12): 18179. doi:10.1592/phco.2005.25.12.1817. PMID 16305301. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=16305301&query_hl=4&itool=pubmed_docsum. Retrieved 2007-02-14.
- ^ Gabapentin Official FDA information, side effects and uses
- ^ Suicidal Behavior and Ideation and Antiepileptic Drugs
- ^ Pfizer Faces First Trial on Neurontin Suicide Claim
- ^ "Huge penalty in drug fraud, Pfizer settles felony case in Neurontin off-label promotion.". San Francisco Chronicle. 2004-05-14. p. C-1. http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2004/05/14/BUGKK6L0LB1.DTL.
- ^ Jane E. Henney, MD (15 Aug 2006). "Editorial: Safeguarding Patient Welfare: Who's In Charge?". Annals of Internal Medicine 145 (4): 305307. PMID 16908923. http://www.annals.org/cgi/content/full/145/4/305?etoc. Retrieved 2006-08-14.
- ^ Baron v. Pfizer, Inc., 2007 N.Y. Slip Op. 05813 (App. N.Y., July 5, 2007)
- ^ Drug Industry Document Archive
- ^ Narrative Review: The Promotion of Gabapentin: An Analysis of Internal Industry Documents - Steinman et al. 145 (4): 284 - Annals of Internal Medicine
External links
Recent Neurontin Forums View All 
Return to Top  Start a New Discussion About this Drug
This article is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License)
http://en.wikipedia.org/wiki/Gabapentin
This information has been independently compiled and is for educational purposes only. It is not intended to be a substitute for face to face medical advice from a qualified healthcare professional. Please remember that the content within this community is totally compiled by users of this site. Our website displays many pages which do not contain any medical information regarding the drug name stated. These pages are only provided for the purpose of opening community discussions about that drug by our users. For more details please see the Disclaimer. This data is Copyright © 2005-2009 PrescriptionDrug-Info.com and is protected under U.S. and International Copyright laws. All Rights Reserved.
drug_details.asp Last Updated November 7 2009
|
 Home Page
Post Your Story or Question
 Follow Us On Twitter
 Registered Community Experts
Topics Submitted 
Prescription Drug Forums
Top 200 Prescription Drugs
Drugs by Category
Recent FDA Approvals
November 2009 Health News
Advertising & Contact Details
About the Community
Medical Disclaimer
Terms of Use
Privacy Policy
Make Us Your Home Page
Bookmark this Page 
Recent Topics
It Methadome
Livogen Z
Pantodac
Pliva 333
Antipyretic
Imprint Mc
Sambong Forte
Hypromellose
Pink Round Pill
Or 60
A 011
Medroxyprogesterone 10mg
Small White Pill G 3742
Small White Round Pill With 74 On One Side And 93 On The Other
Lidoderm
Mutual 105
Hemostan
Pan D
Pill Rx 505
Monowel
Paracetamol
Samsca
Imdur
D5 Nm
Depo Provera
Red Pill 44 453
Neobloc
Tolvaptan
Phentek
Ferrous Sulfate
|
Committed to Your Privacy 
